Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-05-30 @ 3:09 PM
Study NCT ID:
NCT03179904
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-16
First Post:
2017-05-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Keywords: